Webinar: Debunking common PIE misperceptions to enhance your PIE strategy and tactics

Despite FDA guidance around pre-approval information exchange (PIE) for investigational products, misperceptions and ambiguity still exist. So, what are these misperceptions, and how can you overcome them? This webinar will provide the latest payer and manufacturer data to improve your pre-approval communications and help clarify common misperceptions.

Xcenda and FormularyDecisions joined AMCP for a live webinar on March 23, 2022 titled, “Debunking Common PIE Misperceptions to Enhance Your PIE Strategy and Tactics.”

From these presentation slides, you'll learn more on:

• The research on the evolving pre-approval information needs of payers for product evaluation
• How to resolve ambiguity and misperceptions regarding the FDA manufacturer guidance on PIE
• The current strategies and tactics being used by manufacturers and payers to share and evaluate pre-approval information